Drug Shortage Report for ALVESCO

Last updated on 2019-05-11 History
Report ID 80526
Drug Identification Number 02285606
Brand name ALVESCO
Common or Proper name ciclesonide
Company Name ASTRAZENECA CANADA INC
Active Ingredient(s) CICLESONIDE
Strength(s) 100MCG
Dosage form(s) AEROSOL, METERED DOSE
Route of administration INHALATION
Packaging size 120 doses
ATC code R03BA
ATC description OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2019-04-18
Actual start date 2019-04-18
Estimated end date 2019-05-09
Actual end date 2019-05-10
Shortage status Resolved
Updated date 2019-05-11
Company comments Manufacturing capacity constraints
Health Canada comments
Company contact information Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2019-05-11 English Compare
v14 2019-05-10 French Compare
v13 2019-05-10 English Compare
v12 2019-05-03 French Compare
v11 2019-05-03 English Compare
v10 2019-04-26 French Compare
v9 2019-04-26 English Compare
v8 2019-04-19 English Compare
v7 2019-04-18 French Compare
v6 2019-04-18 English Compare
v5 2019-04-05 French Compare
v4 2019-04-05 English Compare
v3 2019-04-04 French Compare
v2 2019-04-04 English Compare
v1 2019-04-04 English Compare